Current pediatric guidelines recommend stimulant medication as a first-line treatment option for ADHD in children aged 6 and older, alongside behavioral therapy — but the decision to use medication, and which one, is individualized and made together with your child’s prescribing clinician, not a one-size-fits-all default [1].
Key takeaways
- For children aged 4–6, behavior parent training is the recommended first-line approach; medication (specifically methylphenidate) may be considered if symptoms remain moderate-to-severe despite behavioral treatment [2].
- For children 6 and older, current guidelines recommend stimulant medication as first-line pharmacological treatment, generally alongside behavioral therapy rather than instead of it [1].
- Common, expected side effects — reduced appetite, sleep changes, headaches, stomach discomfort, irritability — are real but usually improve within the first couple of months of treatment [3].
- A large-scale safety review did not find an association between ADHD medications and serious cardiovascular events (heart attack, stroke, sudden cardiac death) across children, teens, and adults [4][5].
- In June 2025, the FDA updated safety labeling specifically warning about increased weight-loss risk in children younger than 6 taking extended-release stimulants — an important, current safety consideration for this specific age group [6].
What Current Guidelines Recommend, by Age
- Ages 4–6 (preschool): Behavior parent training is the recommended first-line treatment. Clinicians may consider prescribing methylphenidate specifically if symptoms don’t improve with behavioral treatment and there is moderate-to-severe ongoing disturbance in the child’s daily functioning [2].
- Ages 6–12: Current guidelines recommend both behavioral interventions (such as parent training) and pharmacological therapy together, rather than choosing one or the other [1].
- Ages 6 and older, medication specifically: Stimulant medications are recommended as first-line pharmacological treatment. FDA-approved non-stimulant options may be used as an add-on to stimulants, or as the main treatment, depending on the individual situation [1].
No single medication is considered inherently superior to another — the right choice for an individual child depends on factors like how quickly it takes effect, how long it lasts, and how that specific child responds, which is exactly why this decision is made individually with a prescribing clinician rather than through general guidance like this article [7].
Medication Categories, in General Terms
Without getting into specific dosing (which only your child’s prescribing clinician can appropriately determine), ADHD medications generally fall into two broad categories:
- Stimulant medications — the most commonly prescribed first-line category, available in different active ingredient types and in both shorter-acting and longer-acting (extended-release) formulations.
- Non-stimulant medications — used as an alternative or add-on when stimulants aren’t suitable or don’t provide enough benefit alone.
Your child’s clinician will discuss which specific medication and formulation may be appropriate based on your child’s individual health profile, age, and needs.
Common Side Effects
According to AACAP’s official parent medication guide, the most common and predictable side effects of stimulant medication are reduced appetite, some weight loss, difficulty sleeping, headaches, stomach pain, and irritability. These effects are generally described as improving within the first couple of months of treatment for most children [3]. This guide is explicitly noted to have been developed without pharmaceutical industry funding.
What Current Safety Data Actually Shows
It’s worth addressing the more serious safety questions directly and honestly, because they’re a legitimate parental concern:
Cardiovascular safety: A large, completed safety study reviewed by the FDA did not find an association between ADHD medication use and serious cardiovascular events — including stroke, heart attack, and sudden cardiac death — in children and young adults [4]. This is further supported by a more recent systematic review and meta-analysis of 19 observational studies involving over 3.9 million participants, which similarly found no increased cardiovascular risk associated with ADHD medications across children, teens, and adults of any age [5]. That said, the FDA has previously added a cautionary label regarding prescribing for children with pre-existing heart defects specifically — this is exactly the kind of individual health history your child’s clinician will review before prescribing [3].
A current, specific update for young children: In June 2025, the FDA required updated labeling to warn that children younger than 6 years old taking extended-release stimulant medications face a higher risk of weight loss and other side effects than older children taking the same medication — because younger children were found to have higher drug levels in their bodies at the same dose. Extended-release stimulants aren’t approved for children under 6, though they can occasionally be prescribed “off-label” for this age group; this update specifically addresses that situation and is the most current safety information available on this topic [6].
General misuse-related risks: Prescription stimulants do carry risks around misuse and dependence if not used and stored as directed, which is why secure storage, and never sharing medication with anyone else, is part of standard safety guidance for any household with these medications [8].
What Monitoring Typically Looks Like
Ongoing medication management for ADHD typically includes:
- Regular follow-up appointments to monitor how well the medication is working and how your child is tolerating it
- Growth (height/weight) monitoring over time, given the appetite and weight-related effects noted above
- Discussion of any side effects, however minor they may seem
- Periodic reassessment of whether the current medication, dose, or approach continues to be the right fit as your child grows
Practical Next Steps
- If medication is being discussed for your child, prepare specific questions about expected benefits, common side effects, and what monitoring will look like for your child’s specific age and situation.
- Ask directly about the current safety data relevant to your child’s age group, particularly if your child is under 6.
- Never adjust, stop, or change a prescribed medication without first discussing it with the prescribing clinician, even if you have concerns — those concerns are exactly what that conversation is for.
When to Contact Your Child’s Clinician
Contact your child’s prescribing clinician if you notice:
- Side effects that seem severe, unusual, or aren’t improving over time
- Signs of a possible allergic reaction
- Any new or concerning cardiac symptoms (such as chest pain, fainting, or a racing heartbeat that seems abnormal)
- Significant changes in mood, especially new or worsening sadness, hopelessness, or withdrawal
- Any concern at all — a “check with your doctor” conversation is always appropriate and welcomed, not a bother
Frequently Asked Questions
Is ADHD medication safe for children?
Current large-scale safety data has not found an increased risk of serious cardiovascular events from ADHD medication in children. Like any medication, it carries some real, generally mild and manageable side effects, and safety considerations differ somewhat by age — which is why individualized medical guidance matters.
Does starting medication mean other approaches “failed”?
No. Current guidelines generally recommend medication alongside behavioral approaches, not as a replacement for them or a sign that behavioral strategies weren’t good enough. Many children benefit most from combining both.
Will my child need medication forever?
Not necessarily. This is an individualized, ongoing decision made collaboratively with your child’s clinician over time, and can change as your child grows and circumstances change.
Are the side effects permanent?
The most common side effects (appetite changes, sleep changes, headaches) are generally described as temporary and tend to improve within the first couple of months, though this varies by child and should be discussed with your child’s clinician if they persist.
Educational disclaimer: This article is for general educational purposes only and does not constitute medical advice. It does not include, and is not a substitute for, specific dosing information, which only your child’s prescribing clinician can appropriately determine. Never start, stop, or adjust any medication without consulting the prescribing clinician.
Author: BMMC Editorial Team
Medical reviewer: Dr. Abdulnaser Arida, Consultant Psychiatrist and Director, Beautiful Mind Medical Center (given the medication-safety focus of this article, reviewer should verify every safety claim against current prescribing information before publication, and confirm whether naming specific generic medication classes is appropriate for this public-facing context)
Original publication date: [to be set at publishing]
Last medically reviewed: [to be set at publishing]
